On activation by ligand NRG, it can activate the anti-proliferative JAK2-STAT5A pathway which results in activation, dimerization and nuclear localization of the transcription factor STAT5A which promotes transcription of genes mediating differentiation in particular breast cancer cell lines. The gene discussed is JAK2; the disease is breast carcinoma.